Cardiac Calcium Channel Blocker Therapy represents a fundamental aspect of cardiovascular care, offering a targeted approach to managing heart-related conditions. These blockers, recognized as calcium antagonists, exert their therapeutic effects by impeding the entry of calcium ions into cardiac muscle cells. This mechanism proves particularly valuable in addressing diverse cardiovascular issues, ranging from hypertension and angina to specific arrhythmias. By facilitating the dilation of blood vessels and promoting cardiac relaxation, calcium channel blockers contribute to improved blood flow and reduced strain on the heart. The incorporation of these medications into a comprehensive treatment strategy underscores their role in optimizing cardiovascular health. It remains imperative for healthcare professionals to personalize prescriptions based on individual patient profiles, ensuring that the therapeutic benefits are maximized while mitigating potential side effects. The dynamic landscape of Cardiac Calcium Channel Blocker Therapy remains a driving force in advancing cardiovascular medicine and elevating the standard of care for individuals with heart-related conditions.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain